Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2010
08/25/2010EP2219661A1 Compositions for tissue repair/regeneration
08/25/2010EP2219660A1 Modified il-4 mutein receptor antagonists
08/25/2010EP2219655A2 Methods of treating or preventing inflammatory diseases of the intestinal tract
08/25/2010EP2219654A2 Treatment of inflammatory diseases
08/25/2010EP2219611A1 Pharmaceutical forms for the release of active compounds
08/25/2010EP2219607A1 Lh liquid formulations
08/25/2010EP2219604A2 Biomaterial for the controlled delivery of ingredients
08/25/2010EP2219602A1 Aqueous formulation of erythropoiesis stimulating protein stablised by antioxidants for parenteral administration
08/25/2010EP1942925B1 Methods for fusion polypeptide delivery into a cell
08/25/2010EP1908830B1 Non-human gene-disrupted animal having adam11 gene disruption
08/25/2010EP1755647B1 Treatment of amyotrophic lateral sclerosis
08/25/2010EP1594436B1 Mutated neublastin
08/25/2010EP1517892B1 Ring-substituted diphenyl azetidinones, method for the production thereof, medicaments containing said compounds, and use thereof
08/25/2010EP1509545B1 Homotrimeric extended obg3 globular head and uses thereof
08/25/2010EP1339738B1 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
08/25/2010EP1228208B1 36p6d5: secreted tumor antigen
08/25/2010EP1181047B9 Composition comprising alkaline sphingomyelinase of bacterial origin for use as a dietetic preparation, food supplement or pharmaceutical product
08/25/2010EP1100529B2 Thymosin beta 4 promotes wound repair
08/25/2010CN1970574B Double function infusion protein for thrombolysis and anticoagulation , its preparation method and uses
08/25/2010CN1879875B Preparations stabilized over long time
08/25/2010CN1830486B Application of pumpkin protein in preparation of medicine
08/25/2010CN1665524B Use of alanyl-aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors
08/25/2010CN101815724A aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
08/25/2010CN101815530A Therapeutic antibody purification method and method of use
08/25/2010CN101815526A peptide sequences and compositions
08/25/2010CN101815525A Anti-hypertensive agent
08/25/2010CN101815505A Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof
08/25/2010CN101812439A Transdermal structure domain and fusion protein with transdermal action derived from same and preparation method thereof
08/25/2010CN101812438A Arginine deiminase mutant and preparation and application thereof
08/25/2010CN101812436A Agkistrodon acutus venom thrombin-like enzyme, preparation method and application thereof
08/25/2010CN101812135A Fusion protein with high-efficient platelet-increasing role and preparation method thereof
08/25/2010CN101812133A Receptor, the use thereof, and mouse antibodies
08/25/2010CN101812127A Microtubule-associated protein and coding genes and application thereof
08/25/2010CN101812126A Novel HLA-A2 restrictive epitope polypeptide coming from hPEBP4 protein and application thereof
08/25/2010CN101812122A Protection effect of light-harvesting chromoprotein of algae on lens epithelial cells
08/25/2010CN101812118A Specific binding agents of human angiopoietin-2
08/25/2010CN101812040A Corossolone derivative, preparation method and application thereof
08/25/2010CN101810860A Medicinal composition having tumor-resistant synergy
08/25/2010CN101810856A Enzyme containing composition and its use
08/25/2010CN101810855A II-type collagen joint cartilage fluid and preparation method thereof
08/25/2010CN101810854A Novel albumin-free factor VIII formulations
08/25/2010CN101810853A Fibroblast growth factor (FGF) applied to treating depressed scars
08/25/2010CN101810852A Fibroblast growth factor (FGF) applied to treating stretch marks
08/25/2010CN101810851A Fibroblast growth factor (FGF) applied to treating blood streaks
08/25/2010CN101810850A Mouth spraying agent containing cell growth factor and production method thereof
08/25/2010CN101810849A Medicament for curing diabetes
08/25/2010CN101810848A Traditional Chinese medicinal composite for reducing stress response of aquatic animals and preparation method and application thereof
08/25/2010CN101810847A Inflammation-inhibiting compounds
08/25/2010CN101810846A Ointment for treating wound infection of various burns, scalds and cuts
08/25/2010CN101810845A Nutritional agent for enhancing immunity, restoring gastrointestinal function and protecting heart, brain, liver and kidney cells
08/25/2010CN101810583A HIV (Human Immunodeficiency Virus) fusion inhibitor slow-release microsphere
08/25/2010CN101810561A Hirudin polyion micelle composition
08/25/2010CN101810560A Cyclosporine A polymeric micelles composition
08/25/2010CN101810559A Hirudin polyion micelle composition of targeted platelet
08/25/2010CN101810547A Fast dissolving orally consumable films
08/24/2010US7781647 plants and plant cells comprising of functional mammalian enzyme providing N-glycan biosynthesis that is normally not present in plants, for example mammalian beta 1,4-galactosyltransferase; glycoprotein processing in transgenic plants used as cost efficient and contamination safe factories
08/24/2010US7781567 Method for enzymatic production of GLP-2(1-33) and GLP-2(1-34) peptides
08/24/2010US7781566 Peptides, mimetics and antibodies of erbB, TNF, and IgSF receptors; for preventing, treating, and diagnosing mammalian cancer tumors
08/24/2010US7781565 EphA5 receptor targeting fusion protein; having an appropriate binding characteristic to deliver a drug to a cell or cell population
08/24/2010US7781488 convergent assembly of a plurality of pairs of oligopeptides; stable C-terminal disulfide-protected carboxythioester group that can be deprotected to spontaneously generate a free C-terminal thioester; allows a single precursor to participate in a succession of chemical ligation reactions
08/24/2010US7781447 O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders
08/24/2010US7781413 Comprises semaphorin polypeptide (SEMA3B) as tumor suppressor
08/24/2010US7781406 Modulating a transplantation-associated immune response for acute and chronic graft versus host disease (GVHD); kidney, heart and liver allogeneic transplantation; side effect reduction; biodrugs
08/24/2010US7781405 Administering aromatic cationic peptide for targeted mitochondria; antiischemic, -inflammatory, -arthritic, -diabetic agents, liver disorders, stroke; sepsis; viricides; organ removal; neurogenerative diseases; Parkingson's,Alzheimer's, Huntington's diseases; amyotrophic lateral sclerosis
08/24/2010US7781404 Exhibiting improved activity relative to the native insulin-like growth factor 1 and II polypeptide; The fusion component F is selected from the group consisting of a human IgG constant region, Fc domain, and heavy chain; muscle atrophy
08/24/2010US7781402 Methods and implantable devices for treating supraventricular arrhythmias
08/24/2010US7781401 Glucagon-like peptide-2 analogs
08/24/2010US7781400 Pharmaceutical compositions comprising dextran with a molecular weight of 1.0-100 KDA and processes for their preparation
08/24/2010US7781399 Multilayer thin film comprising two or more adjacent layers of oppositely charged polyelectrolytes and encapsulated antigenic peptides; vaccine development;antiarthric agents; multiple sclerosis; autoimmune diseases
08/24/2010US7781398 Drug comprising synthetic peptide analogs for the treatment of cancer
08/24/2010US7781397 Immunoaffinity purification
08/24/2010US7781396 Peptides directed for diagnosis and treatment of amyloid-associated disease
08/24/2010US7781393 Methods for inhibiting tumor cell growth
08/24/2010US7781215 Using hedgehog protein as therapeutic for treatment of bone, reproductive, nervous system and autoimmune disorders
08/24/2010US7781214 introducing a selectable marker that is under the control of a promoter of a gene that is differentially expressed in neural progenitor, culturing in vitro to induce differentiation into neural progenitor cells and selecting for the marker
08/24/2010US7781200 Polypeptides having lipase activity and polynucleotides encoding same
08/24/2010US7781188 Nucleotide and protein sequences of Nogo genes and methods based thereon
08/24/2010US7781180 Marker proteins for diagnosing liver disease and method of diagnosing liver disease using the same
08/24/2010US7781176 Antibodies to HTEEB42 protein
08/24/2010US7781161 Detection cancer; controlling gene expression; detection hybrids
08/24/2010US7781158 Isolating connective tissue protein from porcine bone tissue via pepsin digestion, salt fractionation and ethanol extraction
08/24/2010US7780983 Amphoteric liposomes
08/24/2010US7780970 comprising a live Lactobacillus, an enzyme (glycosyl transferase enzyme, fructosyl transferase enzyme or glucan sucrase ) produced by the micro-organism and an exopolysaccharide (EPS) produced by the activity of the enzyme; food
08/24/2010US7780968 Clostridial toxin derivatives and methods for treating pain
08/24/2010US7780967 Reduced toxicity Clostridial toxin pharmaceutical compositions
08/24/2010US7780965 relates to osteopontin (Eta-1) polypeptides ; for enhancing an immune response in an animal; for therapy and prophylaxis of infectious diseases or cancer; immunization
08/24/2010US7780962 Insertion of viruse genes into cells; administering interferon sensitivity Rna virus; antitumor agents, anticancer agents
08/24/2010US7780960 purification from a recombinant human interferon beta-containing culture by performing affinity chromatography and reversed-phase high-performance liquid chromatography
08/24/2010US7780959 Feline granulocyte macrophage colony stimulating factor nucleic acid molecules
08/24/2010CA2551182C Novel kappa receptor selective opioid peptides
08/24/2010CA2507749C Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
08/24/2010CA2474031C Heterocyclic tripeptides as hepatitis c inhibitors
08/24/2010CA2459011C A bio-security system
08/24/2010CA2436808C Liquid antimicrobial compositions
08/24/2010CA2377560C Incorporation and applications of biomolecular interactions within a carrier
08/24/2010CA2356189C Substance for obtaining highly effective tumor medications as well as a process
08/24/2010CA2345445C A composition for the prevention and/or treatment of atherosclerosis
08/24/2010CA2322716C Use of follistatin to modulate gdf-8 and bmp-11
08/24/2010CA2274985C Synthetic antisense oligodeoxynucleotides targeted to human acetylcholinesterase
08/24/2010CA2273821C Detection and modulation of the iaps and naip for the diagnosis and treatment of proliferative disease
1 ... 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 ... 3163